Cresset Asset Management’s Beam Therapeutics BEAM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $251K | Sell |
14,745
-3,799
| -20% | -$64.6K | ﹤0.01% | 1378 |
|
|
2025
Q1 | $362K | Sell |
18,544
-8,926
| -32% | -$174K | ﹤0.01% | 1212 |
|
|
2024
Q4 | $681K | Sell |
27,470
-10,650
| -28% | -$264K | ﹤0.01% | 938 |
|
|
2024
Q3 | $934K | Sell |
38,120
-8,528
| -18% | -$209K | ﹤0.01% | 1169 |
|
|
2024
Q2 | $1.09M | Buy |
46,648
+36,036
| +340% | +$844K | ﹤0.01% | 984 |
|
|
2024
Q1 | $351K | Buy |
10,612
+289
| +3% | +$9.55K | ﹤0.01% | 1483 |
|
|
2023
Q4 | $281K | Buy |
+10,323
| New | +$281K | ﹤0.01% | 1497 |
|
|
2022
Q1 | – | Sell |
-4,974
| Closed | -$396K | – | 1000 |
|
|
2021
Q4 | $396K | Buy |
4,974
+1,151
| +30% | +$91.6K | ﹤0.01% | 775 |
|
|
2021
Q3 | $333K | Hold |
3,823
| – | – | ﹤0.01% | 800 |
|
|
2021
Q2 | $492K | Sell |
3,823
-5,981
| -61% | -$770K | 0.01% | 556 |
|
|
2021
Q1 | $785K | Buy |
9,804
+7,170
| +272% | +$574K | 0.01% | 356 |
|
|
2020
Q4 | $215K | Buy |
+2,634
| New | +$215K | ﹤0.01% | 687 |
|